Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran
- PMID: 29892483
- PMCID: PMC5992262
- DOI: 10.1016/j.aju.2017.11.017
Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran
Abstract
Objectives: To clarify period prevalence (PP), incidence rate (Ir), and reported mortality for patients with bladder cancer (BC) in Isfahan Province/Iran, as BC is the most common cancer of the urinary tract in Iran and other parts of the world.
Patients and methods: Data from 21 March 2011 to 3 March 2015 was obtained from the Isfahan Cancer Registry. BC was distinguished by the related established topography code (C67). Ir and PP were calculated and expressed per 100 000 persons.
Results: In all, 279 females and 1376 males were identified. For the total population the PP was calculated as 33.2. This value corresponded to a PP of 54.4 for males and 11.4 for females (P < 0.001). Histologically, 63% of patients had invasive BC. Irs versus mortality rates were calculated for each year, i.e. 2011-2012, 2012-2013, 2013-2014, and 2014-2015, as 7.7 vs 0.56, 8.1 vs 0.74, 7.4 vs 0.98, and 9.9 vs 0.84, respectively. The mean (SD, range) age of the patients was 65.2 (13.9, 3-100) years. In relation to the age of the study population, BC occurred in 12% of patients aged <50 years and in 15% of those aged ≥80 years.
Conclusion: The PP for BC in the male population was 4.8-times higher than females. There was a 28.6% increase in the Ir over the study period. Further study concerning environmental exposure, genetic factors, job-related exposure to various chemical carcinogens, and geographical distribution in Isfahan and its' rural provinces would seem to be valuable.
Keywords: BC, bladder cancer; Bladder; Cancer; Incidence; Ir, incidence rate; Isfahan; PP, period prevalence; Prevalence.
Figures
Similar articles
-
Prevalence of lung cancer in Isfahan Province, Iran.J Egypt Natl Canc Inst. 2018 Jun;30(2):57-59. doi: 10.1016/j.jnci.2018.03.001. J Egypt Natl Canc Inst. 2018. PMID: 29691096
-
[Cancers of urinary system, prevalence, demographic].Urologiia. 2019 Dec 31;(6):74-77. Urologiia. 2019. PMID: 32003171 Russian.
-
Prevalence of Stomach Cancer in Isfahan Province, Iran.Gulf J Oncolog. 2018 Sep;1(28):42-45. Gulf J Oncolog. 2018. PMID: 30344133
-
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
-
Genetic and molecular biology of bladder cancer among Iranian patients.Mol Genet Genomic Med. 2020 Jun;8(6):e1233. doi: 10.1002/mgg3.1233. Epub 2020 Apr 6. Mol Genet Genomic Med. 2020. PMID: 32253828 Free PMC article. Review.
Cited by
-
Bladder Cancer in Iran: An Epidemiological Review.Res Rep Urol. 2020 Mar 5;12:91-103. doi: 10.2147/RRU.S232417. eCollection 2020. Res Rep Urol. 2020. PMID: 32185152 Free PMC article. Review.
-
A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.Contemp Oncol (Pozn). 2019;23(1):7-15. doi: 10.5114/wo.2019.84112. Epub 2019 Apr 5. Contemp Oncol (Pozn). 2019. PMID: 31061631 Free PMC article. Review.
References
-
- Silverman D.T., Hartge P., Morrison A.S., Devesa S.S. Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 1992;6:1–30. - PubMed
-
- Pashos C.L., Botteman M.F., Laskin B.L., Redaelli A. Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract. 2002;10:311–322. - PubMed
-
- Rugo H.S. Occupational cancer. In: Ladou J., editor. Current occupational and environmental medicine. 3rd ed. McGraw-Hill Companies Inc.; New York: 2004. pp. 229–268.
-
- Ruder A.M., Carreon T., Ward E.M. Bladder cancer. In: Rosenstock L., Cullen M.R., editors. Clinical occupational and environmental medicine. 2nd ed. Elsevier; Philadelphia: 2005. pp. 757–766.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous